Aaron Ritter, MD
Primary Location
Lou Ruvo Center for Brain Health - Las Vegas
- Appointment:
- 702.483.6000
- Fax:
- 702.483.6028
Treatment & Services
- Alzheimer's
- Consultation, Evaluation, And Treatment Adult Neurological Disorders
Specialty in Diseases & Conditions
- Alzheimer's
- Alzheimer's and Dementia
- Cognitive Disorders
- Dementia with Lewy Bodies
- Encephalopathy
- Frontotemporal Dementia (FTD)
- Memory Loss
Insurance
Is Cleveland Clinic Nevada Part of Your Insurance?
For questions about accepted insurance plans for our Nevada locations and specific plan products including Medicare, please contact your insurance carrier directly.
View All PlansAbout Aaron Ritter, MD
Aaron Ritter, MD, Associate Staff, Neuropsychiatry and Behavioral Neurology
Dr. Ritter initially joined the Cleveland Clinic Lou Ruvo Center for Brain Health in July 2014 as a clinical fellow in Behavioral Neurology and Neuropsychiatry. Dr. Ritter comes to Las Vegas from Tucson following completion of his internship (in pediatrics) and three year residency (in psychiatry) at the University of Arizona.
At the University of Arizona, Dr. Ritter was involved in research projects looking at the neurocircuitry of emotional disorders, the effect of hypothyroidism on mood states, and psychiatric presentations of neurodegenerative disorders. He received two research awards from the University of Arizona for his work on these projects. In addition, Dr. Ritter developed a strong interest in medical education. Following completion of his internship, he received a distinguished teaching award that recognized him as one of the top three “resident educators” out of a pool of more than 600 residents and fellows.
During his two year clinical fellowship at the Lou Ruvo Center for Brain Health, Dr. Ritter received further training in diagnosing and treating neurodegenerative disorders such as Alzheimer’s disease, frontotemporal dementia, dementia with Lewy bodies, and chronic traumatic encephalopathy.
Education & Professional Highlights
Appointed
2016
Education & Fellowships
Fellowship - Cleveland Clinic Lou Ruvo Center for Brain Health
Behavioral Neurology and Neuropsychiatry
Las Vegas,
NV USA
2016
Fellowship - Behavioral Neurology Neuropsychiatry
2016
Residency - University of Arizona Medical Center
Psychiatry
Tucson,
AZ USA
2014
Residency - University of Arizona Medical Center
Pediatrics
Tucson,
AZ USA
2011
Medical Education - University of Colorado School of Medicine
Denver,
CO USA
2010
Undergraduate - University of Wisconsin
Madison,
WI USA
2004
Additional Training
Fellowship in Behavioral Neurology and Neuropsychiatry
Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas NV
7/2014-6/2016Residency in Psychiatry
University of Arizona, Tucson, AZ
7/2011-6/2014Internship
University of Arizona, Tucson, AZ
7/2010-6/2011Medical Degree
University of Colorado School of Medicine, Denver, Colorado
8/2006-6/2010Bachelor of Arts
University of Wisconsin, Madison, Wisconsin
9/2001-12/2004BOARD CERTIFICATIONS:
2014-Present National Board ofMedical Examiners
2017-Present American Board ofPsychiatry and Neurology (Psychiatry)
2018-Present United Council ofNeurological Subspecialties (Behavioral Neurology and Neuropsychiatry)
Professional Highlights
ORIGINAL PUBLICATIONS IN PEERREVIEWED JOURNALS
- Ritter A, Pillai JA, Treatment ofVascular Cognitive Impairment. Curr Treat Options Neurol. 2015Aug;17(8):367.
Ritter A, Cummings JL, FluidBiomarkers in Clinical Trials of Alzheimer's Disease Therapeutics. FrontNeurol. 2015 Aug 31;6:186.
Ritter A, Banks SA, Hawley, N, Miller, J. The Association between Montreal Cognitive Assessment Memory Scores andHippocampal Volume in a Neurodegenerative Disease Sample. Journal ofAlzheimer’s Disease. 2017 June.
Ritter A, Banks, SA, Leger, G, Miller, J, Neuropsychological testing in pathologically verified Alzheimer’sdisease and frontotemporal dementia: How well do the Uniform Data Set measuresdifferentiate between diseases? Alzheimer’s Disease and AssociatedDisorders. 2017 July.
Cummings JC,Lee G, Mortsdorf T, Ritter A, ZhongK, Alzheimer’s disease drug developmentpipeline: 2017. Alzheimer’s and Dementia: Translational Research andClinical Interventions. 2017 Sept.
- Cummings J, Ritter A, Zhong K.Clinical Trials for Disease-Modifying Therapies inAlzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future. JAlzheimer’s Dis. 2018
- Cummings JC, Lee G, Mortsdorf T, Ritter A, Zhong K, Alzheimer’s disease drug development pipeline: 2018. Alzheimer’sand Dementia: Translational Research and Clinical Interventions. 2018
- Ritter A, Miller JB, Cummings JC ,Nance C ,Neuroscience learning from longitudinalcohort studies of Alzheimer's disease: Lessons for disease-modifying drugprograms and an introduction to the Center for Neurodegeneration andTranslational Neuroscience. Alzheimer’sDementia; Translational Research and Clinical Interventions.2018 Jul
- Shan G, Banks S, Miller JB, Ritter A, Bernick C,Lombardo J, Cummings JC, Statisticaladvances in clinical trials and clinical research. Alzheimer’sDement (N Y). 2018
- Nance C,Ritter A,Miller JB,Lapin B,Banks SJ, The Pathology of RapidCognitive Decline in Clinically Diagnosed Alzheimer's Disease JAlzheimer’s Dis. 2019 Jul 8
- Cummings J,Lee G,Ritter A,Sabbagh M,Zhong K.Alzheimer's disease drug developmentpipeline: 2019. Alzheimer’sDement (N Y). 2019 Jul 9
- ummings, J., Ritter, A, Rothenberg, K., Advancesin Management of Neuropsychiatric Syndromes in Neurodegenerative Diseases CurrentPsychiatry Reports. 2019 Aug.
- MishraVR, Sreenivasan KR, Yang Z, Zhuang X, Cordes D, Mari Z, Litvan I, Fernandez HH,Eidelberg D, Ritter A, Cummings JL,Walsh RR. Unique white matter structuralconnectivity in early-stage, drug-naive Parkinson disease. Neurology.2019 Dec.
- DecourtB, Wilson J, Ritter A, et al.MCLENA-1: A Phase II Clinical Trial for the Assessment of Safety, Tolerability,and Efficacy of Lenalidomide in Patients with Mild Cognitive Impairment Due toAlzheimer's Disease. Open Access J Clin Trials. 2020;12:1-13. doi:10.2147/oajct.s221914
BOOK CHAPTERS:
- Ritter A., and Cummings J (2016), FluidBiomarkers in Clinical Trials of Alzheimer’s Disease Therapeutics.Biomarkers of Alzheimer’s Disease: The Present and the Future. FrontiersResearch Topics.
Ritter A., and Pillai J, (2017). VascularCognitive Impairment. Neurogeriatrics. Springer Publishing.
PUBLISHED ABSTRACTS/POSTERS:
- Ritter A, Taylor E. Neurocircuitryto Explain Neuropsychiatric Symptoms. Poster Presentation at AmericanNeuropsychiatric Association Annual Conference, Boston, MA 2014.
Ritter A, Frontal Lobe Syndrome in aPatient Thirty Years Following Anterior Cingulotomy. Poster Presentation atUniversity of Arizona Research Symposium, Tucson, Arizona 2014.
Ritter A, Revisiting MyxedemaMadness: A Case Report, Review of the Literature, and Proposed Pathophysiology.The Journal of Neuropsychiatry and Clinical Neurosciences.APPI-JN-14-09-0222.R1. Poster Presentation at American NeuropsychiatricAssociation Annual Conference, Orlando FL, 2015.
Ritter, A, Hawley, N, Banks, S, and Miller, J. The association between Montreal Cognitive Assessment memory scores andhippocampal volume in a neurodegenerative disease sample. PosterPresentation at International Neuropsychological Society, New Orleans, LA,2017.
Ritter A, Lee G, Zhong, K and Cummings, J, Alzheimer’s drug diseasedevelopment pipeline: 2017. Poster Presentation at Clinical Trials: Alzheimer’sDisease, Boston, MA 2017.
Nance, C, Ritter, A, Miller, J, Banks, S, Predictorsof Rapid Cognitive Decline in the NACC Database. Neurology. 2018 P1.186.90 15Supplement.
Ritter, A., Calvin, C., Ibarra, M. Cummings, J. A. The Clinical Core of theCenter for Neurodegeneration and Translational Research: A Novel Approach tothe Study of Alzheimer's and Parkinson's Disease. Abstract represented at:National Idea Symposium of Biomedical Research Excellence (NISBRE), Washington,D.C. June 2018. https://www.eiseverywhere.com/ehome/nisbre/533156/.
Ritter, A., Hartley-Mack, K., Ibarra, M., Cummings, J., A Novel Approach toRecruitment for Alzheimer’s Disease Research: The Experience of the Center forNeurodegeneration and Translational Neuroscience (CNCN). Abstract representedat: National Idea Symposium of Biomedical Research Excellence (NISBRE),Washington, D.C. June 2018. https://www.eiseverywhere.com/ehome/nisbre/533156/.
J. Bayram,E. Sreenivasan, K, Ritter, A.Caldwell, J. Cognitive Correlates of Amyloid Deposition. Presentation atInternational Neuropsychological International Meeting. New York, NY. February2019.
Longhurst, J., Ritter, A., Rider, J., and Landers,Merrill. Physical therapy is Associatedwith Improvements in Gait and Balance in Individuals with Lewy Body Dementia: ARetrospective Analysis. Presentation at the International Lewy BodyConference. Las Vegas, NV. June 25, 2019.
Mishra V.,Sreenivasan K.R., Bayram E., Banks S., Longhurst J., Yang Z., Zhuang X., CordesD., Ritter A., Caldwell J., Bluett B.(2019). Disrupted Structural Organization in Parkinson’s Disease Patients Withand Without Memory Impairment. 25th Annual Meeting of the Organization forHuman Brain Mapping.
SreenivasanK.R., Bayram E., Banks S., Longhurst J., Zhuang X., Yang Z., Cordes D., Ritter A., Caldwell J., Bluett B.,Mishra V. (2019). Claustrum Functional Connectivity in Parkinson’s DiseasePatients with Mild Cognitive Impairment. 25th Annual Meeting of theOrganization for Human Brain Mapping.
SreenivasanK.R., Bayram E., Banks S., Longhurst J., Yang Z., Zhuang X., Cordes D., Ritter A., Caldwell J., Bluett B.,Mishra V. (2019). Functional Network Topology in Parkinson’s Disease Patientswith Mild Cognitive Impairment. 25th Annual Meeting of the Organization forHuman Brain Mapping.
Bayram E.,Sreenivasan K.R., Longhurst J., Banks S., Yang Z., Zhuang X., Cordes D., Ritter A., Caldwell J., Bluett B.,Mishra V. (2019). Associations Between Dual Task Cost and Striatal FunctionalConnectivity in Parkinson’s Disease with Mild Cognitive Impairment.International Society for Magnetic Resonance in Medicine 27th Annual Meeting& Exhibition.
Mishra V.,Sreenivasan K.R., Bayram E., Banks S., Longhurst J., Yang Z., Zhuang X., CordesD., Ritter A., Caldwell J., BluettB. (2019). Towards identification of neuroanatomical correlates ofneuropsychological scores in Parkinson’s disease patients, with and without,memory impairment. International Society for Magnetic Resonance in Medicine27th Annual Meeting & Exhibition.
SreenivasanK.R., Bayram E., Banks S., Longhurst J., Yang Z., Zhuang X., Cordes D., Ritter A., Caldwell J., Bluett B.,Mishra V. (2019). Aberrant Functional Connectivity and Network Topology inParkinson’s Disease Patients with Mild Cognitive Impairment. InternationalSociety for Magnetic Resonance in Medicine 27th Annual Meeting &Exhibition.
SreenivasanK.R., Bayram E., Banks S., Longhurst J., Zhuang X., Yang Z., Cordes D., Ritter A., Caldwell J., Bluett B.,Mishra V. (2019). Altered Claustral Functional Connectivity in Parkinson’sdisease Patients with Mild Cognitive Impairment. International Society forMagnetic Resonance in Medicine 27th Annual Meeting & Exhibition.
Ritter A and Mishra V. Investigating the Sensitivity ofFree-Water Imaging in Detecting White-Matter Abnormalities within Patients withAlzheimer’s Disease. Alzheimer's & Dementia: The Journal of the Alzheimer'sAssociation, Volume 15, Issue 7, P762 - P763. July 2019
Ritter Aand Calvin, K. Sensitivity of the Montreal Cognitive Assessment to AmyloidPathology in a Mixed Clinical Sample, Poster. Alzheimer's & Dementia: TheJournal of the Alzheimer's Association, Volume 15, Issue 7, P360. July 2019
Hawley, N.,Bennett, L., Ritter, A., An Unbiased Biomarker Approach toNeuropsychological, Behavioral, and Psychiatric Symptoms in a Mixed ClinicalSample, Volume 34, Issue 6, August 2019, Page 1029. https://doi.org/10.1093/arclin/acz034.164
Hawley, N.,Bennett, L., Ritter, A., The Sensitivity and Specificity of theMontreal Cognitive Assessment is Age Dependent for Amyloid Positivity in aMixed Clinical Sample. Archives of Clinical Neuropsychology, Volume 34,Issue 6, August 2019, Page 1030. https://doi.org/10.1093/arclin/acz034.165
Longhurst, J.,Caldwell, J.Z.K., Ritter, A.,Mishra, V., Bluett, B., & Landers, M. The cognitive profiles of individualswith freezing of gait differs among freezing of gait subtypes in Parkinson'sdisease. Poster submitted for the 2019 Annual Meeting of the InternationalCongress of Parkinson's Disease and Movement Disorders, Nice, September 22-26.
Caldwell, J.Z.K.,Zhuang, X., Ritter, A., Sreenivasan,K., Mishra, V., Cummings, J., Banks, S., & Cordes, D. Relationship of verbalmemory to default mode network volume differs by sex and amyloid status. Presentation accepted for the 2019NIH IDeA Western Regional Conference, Las Vegas, October 7-9.
Kaylegian, J., Ritter, A., & Caldwell, J.Z.K.Impairment Rating Discrepancies in a Longitudinal Observational Alzheimer'sStudy. Poster submitted for the 2019 NIH IDeA Western Regional Conference, LasVegas, October 7-9.
Ritter Aand Calvin K, Can Results from the Brief Smell Identification Test (BSIT)Predict Amyloid PET Results? Sensitivity and Specificity Analyses in a MixedSCI and MCI Population. (Accepted for Presentation at the 2019 Western IDeAWestern Regional Conference, October 2019, Las Vegas, NV)
Matthews,D., Ritter, A., Thomas, R., Andrews,R., Luckic, A., Revta, C., Tousi, B., Leverenz, J., Fillit, H., Zhong, K.,Feldman, H., Cummings, J., The Effects ofRasagiline Upon Glucose Metabolism, Cognition, and Tau in Patients With Mild toModerate Alzheimer’s Disease: Results of a Phase II Clinical Trial.OC19-The Journal of Prevention of Alzheimer’s Disease-JPAD. Volume 6,Supplement 1, 2019.
Ritter A.,K. Zhong, G. Lee, J.Cummings, M. Sabbagh. Alzheimer’sDisease Drug Development Pipeline: 2019. Alzheimer’s Disease DrugDevelopment Pipeline: 2019. P043 The Journal of Prevention of Alzheimer’sDisease-JPAD. Volume 6, Supplement 1, 2019.
Mishra, V., Ritter, A., Cordes, D., Caldwell, Diffusion Kurtosis Imaging Suggests SexSpecific Alteration of White Matter in Mild Cognitively Impaired Participants (acceptedfor publication at AAIC-2020)
Mishra, V.,Caldwell, C., Cordes, D., Shan, G.,Ritter, A., Diffusion MRI-DerivedFree Water Fraction May be a Sensitive Imaging Biomarker that could ImproveIdentification of Mild Cognitive Impairment Participants progressing toAlzheimer’s disease-dementia. (accepted for publication at AAIC-2020)
Sreenivasan K,Zhuang X, Longhurst J, Yang Z, Cordes D, RitterA, Caldwell J, Mari Z, Litvan I, Bluett B and Mishra V. Resting statefunctional connectivity in levodopa non responsive Parkinson’s disease patientswith freezing of gait. 2020 International Association of Parkinsonism andRelated Disorders.
Mishra V,Sreenivasan K, Cordes D, Ritter A,Miller J, Mari Z, Litvan I, and Caldwell J. Investigating the sensitivity offree-water corrected diffusion-weighted MRI measures to understand sex-specificalterations in Parkinson’s disease with mild cognitive impairment. 2020International Association of Parkinsonism and Related Disorders.
RESEARCH ACTIVITIES:
FUNDEDRESEARCH, GRANTS, CLINICAL TRIALS:
2016-2020 GlobalAlzheimer’s Platform (GAP)
PrimaryInvestigator ($100,000)
2016-Present Centerfor Neurodegeneration and Translational Research (CNTN) NIGMS: P20GM109025; Director,Clinical and Translational Research Core
2019 Influenceof Amyloid on Cognition, Cleveland Clinic Catalyst Grant
PrimaryInvestigator ($75,000)
2019-Present BrainHealth in Professional Athletes
Co-Investigator
2020-Present LouRuvo Center for Brain Health Brain Donation Program, Marlon Foundation Grant; Co-Investigator($100,000)
CLINICALTRIALS:
Alzheimer’s Disease
2014-2016 EXPEDITION3 (Eli Lilly),
Site Sub-Investigator
2014-2016 IDEASStudy (CMS/Eli Lilly),
Site Primary Investigator
2014-2018 TOMMORROWStudy (Takeda),
Site Primary Investigator
2014-2018 DISINHIBITIONStudy (Avanir Pharmaceuticals),
Site Sub-Investigator
2014-2018 R2Study (ADDF/Avid/Takeda),
Site Co-Investigator
2016-2017 EARLYSTUDY (Janssen),
Site, Sub-Investigator
2016-2019 GENEMATCHStudy (Banner Health),
Site Primary Investigator
2016-2019 CREADII Study (Genentech),
Site Co-Investigator
2016-2019 EMERGEStudy (Biogen),
Site Primary Investigator
2016-2020 GENERATIONStudy (Novartis),
Site Primary Investigator
2016-current LEARNStudy (Alzheimer’s Assoc/NIA),
Site Primary Investigator
2016-current Healthybrains.org(Cleveland Clinic),
Site Sub-Investigator
2016-current A4Study (Eli Lily),
Site Primary Investigator
2016-current EXERTStudy (ADCS),
Site Blinded Investigator
2016-current ADNI3 Study (University of Southern California),
Site Sub-Investigator
2017-2020 MISSIONAD Study (Eisai),
Site PrimaryInvestigator
2018-current nQMedical (nQ),
Primary Investigator
2018-current S-CitADStudy (JHSPH),
Site Primary Investigator
2018-current T2TRIPROTECT Study (Biohaven),
Site Primary Investigator
2018-current GRADUATEII Study (Genentech),
Site Primary Investigator
2019-current OPTINAStudy (Optina),
Primary Investigator
2019-current MCLENA-1Study (NIH),
Site Sub-Investigator
2019-current CLARITYStudy (Eisai),
Site Primary Investigator
2019-current GAINStudy (Cortexyme),
Site Primary Investigator
2019—current TRCPAD Study (NIA/ATRI),
Site Sub-Investigator
2020-current EMBARKStudy (Biogen), S
ite Primary Investigator
BipolarDisorder
2012-2014 DCSStudy (University of Arizona),
Sub-Investigator
Chronic Traumatic Encephalopathy
2016-current ProfessionalFighter’s Study (CCLRCBH Philanthropy),
Co-Investigator
2016-current DIAGNOSECTE Study (NINDS),
Site Sub-Investigator
Dementia with Lewy Bodies
2016-current PRESENCEStudy (Eli Lilly),
Site Sub-Investigator
2019-current ASCEND-LBStudy (EIP Pharma),
Site Primary Investigator
Frontotemporal Dementia
2020-current ALLFTDStudy (NIA and NINDS),
Site Primary Investigator
Huntington’s Disease
2016-current ENROLLHD Study (CHDI Foundation),
Site Sub-Investigator
Multiple Sclerosis
2016-2018 AFFINITYStudy (Biogen),
Site Sub-Investigator
2016-2019 CHORDSStudy (Genentech),
Site Sub-Investigator
2016-current BAF312Study (Novartis),
Site Sub-Investigator
2016-current ENSEMBLEStudy (Roche),
Site Sub-Investigator
2016-current FLUENTStudy (Novartis),
Site Sub-Investigator
2016-current ESTEEMStudy (Biogen),
Site Sub-Investigator
2017-current ARISEStudy (UTSW),
Site Sub-Investigator
2017-current ALTHIOSStudy (Novartis),
Site Sub-Investigator
2017-current NOVAStudy (Biogen),
Site Sub-Investigator
2018-current DAYBREAK(Celgene),
Site Sub-Investigator
2018-current MSPATHS (Biogen),
Site Sub-Investigator
2018-current ULTIMATE2 (TG Therapeutics),
Site Sub-Investigator
Parkinson’s Disease
2016-2018 NILOPD Study (Northwestern University),
Site Sub-Investigator
2018-Present INSYTEStudy (Acadia),
Site:Primary Investigator
Progressive Supranuclear Palsy
2017-2019 ARISEStudy (AbbVie),
Site Co-Investigator
INVESTIGATIONAL NEW DRUG DEVICES HELD:
2018-Present GE-180
Certifications
- Psychiatry
Specialty Interests
Alzheimer's disease, Lewy body Disease, Vascular dementia, Chronic Traumatic Encephalopathy
Awards & Honors
2012 Dean’s List in Excellencein Teaching by a Houseofficer 2010-2011, University of Arizona
2013 Junior Resident Award forBest Overall Performance for 2012-2013, University of Arizona
2014 GMEResident Excellence and Leadership Scholarship for 2012-2013, University ofArizona
2014 Ely Lily Research Awardfor 2013-2014, University of Arizona
2015 ClevelandClinic Excellence in Teaching Award for 2014-2015
2016 ClevelandClinic Excellence in Teaching Award for 2015-2016
2018 2018 Innovator Healthcare Hero, Anthem BlueCross BlueShield andNevada Business Magazine
2019 The Dr. Roy Martin 2019 Las Vegas HEALSInspired Excellence in Healthcare Award
2020 KeyNote Speaker, Touro Research Day; Touro University, Henderson, NV
2020 2020Alzheimer’s Award for the article: The Pathology of Rapid Cognitive Decline in ClinicallyDiagnosed Alzheimer's Disease Journal of Alzheimer’sDisease
Memberships
AmericanNeuropsychiatry Association
2014-Present Member
InternationalParkinson and Movement Disorder Society (MDS)
2016-2018 Member
AmericanAcademy of Neurology
2017-Present Member
InternationalSociety to Advance Alzheimer’s Research and Treatment (ISTAART)
2017-Present Member
Research & Publications
See publications for Aaron Ritter, MD.
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 9/8/2019, Dr. Ritter has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.
* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.
310 Patient Satisfaction Reviews
The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Cleveland Clinic.
| Overall | Star Ratings | |
|---|---|---|
| Explains | 4.9 | |
| Courtesy, Respect & Concern | 5 | |
| Patient Rating of Doctor | 5 |
79 Patient Comments
© 2020 The Cleveland Clinic Foundation. All Rights Reserved. No part of this work may be altered, reproduced, stored in a retrieval system, or transmitted, in any form, by any means, whether electronic, mechanical, by photocopying, recording, or otherwise, without the prior written permission of the Cleveland Clinic.
Reviewed on Jul 16, 2020
It was a good experience. We live so far away from any specialty doctors that the online visit was very convenient for us.
Reviewed on Jul 16, 2020
Dr. Ritter explained some of the difficulties we were having. He explained the CT and MRI results. He gave us options to help slow the problem.
Reviewed on Jul 9, 2020
Dr. Ritter is an exceptional doctor and I may fortunate to be his patient.
Reviewed on Jun 30, 2020
We were pleased to be able to meet directly with Dr. Ritter this time.
Reviewed on Jun 30, 2020
we have other physicians that we go to for different medical issues, and a majority of them do a nice job of explaining things to the patient. however, our experience with the Cleveland Clinic has been above and beyond what we expected. we always feel like everyone we interact with at the clinic, has the upmost concern and willingness to make sure we are taken care of and informed why procedures and programs are being given to us to help facilitate and/or help with our situation(s)..We are TRULY fortunate to have the Cleveland Clinic beside us through this chapter in our lives!!
Reviewed on Jun 16, 2020
We have had a good experience with Doctor Ritter, my Mom really loves talking with him. He treats her with compassion and understanding. Thank you
Reviewed on Jun 12, 2020
great doctor, very informative. gave us positive vibes
Reviewed on Jun 10, 2020
Dr. Ritter is an excellent doctor. He always takes time to discuss and answer any questions that we may have. He is always up to date in understanding Sophia's situation currently as I have informed him. He is always not only concerned about the well being of the patient but also the wellbeing of the caregiver.
Reviewed on Jun 3, 2020
Dr. Ritter is incredibly caring and knowledgeable.
Reviewed on Jun 3, 2020
reaching Dr Ritter by my chart has been very easy.
Reviewed on Jun 3, 2020
we are totally grateful for dr Ritter
Reviewed on Jun 2, 2020
Dr Ritter was very caring , professional, knowledgeable and a great listener with lots of empathy for mom's issues and our concerns.He took the time to answer our questions and speak to mom and ask her questions about her health .Last appointment he gave her a referral to a Cardiologist and we are thankful her blood pressure now is controlled and we are running tests to improve mom's health.Also important he's very friendly and patient , we look forward to future appointmentswith him.
Reviewed on May 29, 2020
Dr Ritter was efficient knowledgeable polite listened snd processed what i said and responded. i am very happy having him as my dr.
Reviewed on May 22, 2020
Dr. Ritter is a very caring, considerate and thorough doctor.
Reviewed on May 21, 2020
we are do pleased with Dr. Ritter. he is just excellent.
Reviewed on May 19, 2020
he was friendly,very knowledgeable and took the time to answer all of our questions. dr. Ritter is a definite asset to the Cleveland clinic!
Reviewed on May 8, 2020
Dr. Ritter is always professional, kind, and patient with us.
Reviewed on May 7, 2020
Dr Ritter is so great, we're so happy he's ours. Always very honest and explains
Reviewed on May 7, 2020
We love being with Dr Ritter, video is easy and love seeing him in person too. it's hard to compare.
Reviewed on Apr 29, 2020
Dr. Ritter was kind caring and thorough
Reviewed on Apr 16, 2020
Excellent physician; very compassionate
Reviewed on Apr 2, 2020
Dr. Ritter is the best. He is professional and deeply caring.
Reviewed on Mar 13, 2020
I'm fortunate to be under the care and guidance of Dr. Aaron Ritter. I'm extremely grateful and have high regard for the Cleveland Clinic and the Lou Ruvo facility.
Reviewed on Mar 13, 2020
I will not hesitate to recommend Dr. Ritter to others that may benefit from his knowledge, compassion and care.
Reviewed on Mar 6, 2020
He was super, young, but very helpful. He made me feel at ease during the whole process. I liked the options I could pursue. When i chose the one that was the least treatment he agreed with me. I would not be hesitant to talk to him again about my mental health. I would surely recommend him to my friends and family. And I as well, also recommend the Center. Dr. Ritter was very good.
Reviewed on Mar 5, 2020
he is very good doctor and caring.
Reviewed on Mar 5, 2020
Dr. Ritter was impressive due to his level of professionalism, approach, knowledge, concern, analogies and explanations.
Reviewed on Mar 5, 2020
I let my daughters go in lieu if myself. They were very impressed with the Dr and the facility.
Reviewed on Mar 4, 2020
dr Ritter is a very KIND person
Reviewed on Feb 26, 2020
Very good experience with Dr. Ritter.
Reviewed on Feb 20, 2020
Everything went like clockwork. All personnel were very kind. We were very pleased with Dr. Ritter. Only wish there was a facility on the south end of town.
Reviewed on Feb 18, 2020
best doctor
Reviewed on Feb 14, 2020
Dr Ritter is the best doctor in town
Reviewed on Feb 11, 2020
My concierge doctor, Sean Ameli,MD, recommended Dr Ritter and his staff person arranged an appointment within a few days. Previously, I had a number of appointments at Cleveland Clinic and accomplished little; and, Dr. Ritter has taken charge and has me on the road to having an understanding of my memory issues. I am favorably impressed.
Reviewed on Feb 7, 2020
Dr Ratter is very friendly and very much care for patient
Reviewed on Feb 7, 2020
I am very pleased with my visit. Everyone was very friendly and professional. I really like Dr. Ritter. I am happy with my visit.
Reviewed on Feb 5, 2020
Very good experience. Dr Ritter was very informative and courteous. The nurses were also very amiable.
Reviewed on Feb 5, 2020
The care provider was very good and both respectful and courteous and was not bothered by my questions and answered them to my satisfaction.
Reviewed on Jan 30, 2020
excellent! Dr . Ridder is very impressionable we understood one another and he clearly explained all issues and concerns that I had . we got along very well. Please tell him thank you for me and the staff as well.
Reviewed on Jan 29, 2020
Dr. Ritter was exceptionally kind, and concerned, about what we were facing. He asked me many questions about everyday life with my husband's Alzheimer's and listened as I explained all the variations of his behavior. He seemed honestly regretful that my husband is not eligible for available therapies and possible trials as he has also suffered two strokes in recent years. He asked me several times how I am doing and encouraged me to explore the care-giver services available.
Reviewed on Jan 28, 2020
I was very pleased with Dr. Ritter and am looking forward to finding solutions for my concerns.
Reviewed on Jan 23, 2020
Dr Ritter was excellent
Reviewed on Jan 15, 2020
Dr. Ritter was very attentive, listened to our concerns and offered solutions. He also showed compassion, which is extremely important. He was interested in the caregiver as well as the patient.
Reviewed on Jan 2, 2020
Dr. Ritter is wonderful. He took so much time with us and explained everything in a way we could understand. All doctors should take a "bedside manners " course from him! We consider ourselves extremely lucky that we were assigned to him.
Reviewed on Dec 30, 2019
it always amazes me that Dr Ritter is so calm and sincere with his guidance. he patiently explains why he is making changes to my routine, and what results I should expect from those changes. That makes me comfortable with his decisions.
Reviewed on Dec 20, 2019
I appreciate Dr. Ritter for his honesty, effort and bedside manner. He explained my unique situation with clarity and made no unreal promises. He's fantastic!
Reviewed on Nov 27, 2019
Dr Ritter was informative, curtious and showed concern.
Reviewed on Nov 26, 2019
Dr Ritter was great, he asked great questions narrowed down what could contribute to my memory gaps and have great solutions and then said I could follow up if those things were not working! excellent Neurologist! I would highly recommend him!
Reviewed on Nov 21, 2019
I was quite impressed with Dr Ritter.
Reviewed on Nov 8, 2019
DR. Ritter is incredibly kind, caring, knowledgeable, and professional.
Reviewed on Nov 7, 2019
Dr. Ritter is very kind and considerate, My Sister and I never have a question he doesn't answer.
Reviewed on Oct 30, 2019
Dr. Ritter is an amazing professional. Highly competent, kind, and takes the time to fully explain what's going on with my mom. I couldn't ask for a better doctor.
Reviewed on Oct 22, 2019
Dr. Ritter is great! He is engaged and listens. He is respectful and caring.
Reviewed on Oct 16, 2019
Dr. Ritter and his staff are excellent, very caring, understanding and compassionate.
Reviewed on Oct 15, 2019
Dr. Ritter is a great listener and makes me feel like he's not rushed and takes ownership of my situation
Reviewed on Oct 14, 2019
Dr. Ritter was so awesome with my dad. I really appreciate how attentive he was, yet how he understood when I gave him information about my dad's health that my dad cannot express about himself due to his memory loss.
Reviewed on Oct 11, 2019
Dr Ritter is awesome and very patient
Reviewed on Oct 10, 2019
hopefully nobody will need an alzheimer's dr but if they do I will definitely give them a referral
Reviewed on Oct 3, 2019
Excellent visit. Dr. Ritter was very understanding, answered all of our questions and provided us with enough information to make good decisions.
Reviewed on Oct 1, 2019
Dr. Ritter is very good, understanding, professional, not rushed and listens!
Reviewed on Sep 19, 2019
I was very happy with how quick I was able to see Dr. Ritter.
Reviewed on Sep 13, 2019
Dr. Ritter is a very compassionate doctor and we enjoyed our visit very much. Dr. Ritter was helpful with information regarding activities at the center which we are very interested in, and he has a very pleasant manner about him. He was very thorough in his questions and care, and we left feeling very confident and without any questions or concerns.
Reviewed on Sep 11, 2019
I was/am very impressed with Dr. Ritter's concern for my challenges. I will not hesitate to recommend him to anyone in need of his/your services.
Reviewed on Sep 9, 2019
love Dr Ritter....he cares for the caregiver ad well as the patient
Reviewed on Sep 6, 2019
Dr. Ritter is always very kind and compassionate.
Reviewed on Sep 6, 2019
I liked that the Dr. gave the patient eye contact at all times as though he was an important person.
Reviewed on Sep 5, 2019
I was very happy with my meeting with Dr. Ritter. he was prepared and I feel that we had a good session. I look forward to another opportunity. we also appreciate your time.
Reviewed on Sep 4, 2019
Dr Ritter is very kind, and educated.
Reviewed on Aug 30, 2019
Dr Ritter provided the information I wanted, which was directly related to the results of tests done over time that showed my level of functioning currently and what's expected in the future.
Reviewed on Aug 28, 2019
Dr. Ritter was by far the best MD I have ever seen.
Reviewed on Aug 28, 2019
Wonderful Doctor. He explains everything very well, has time and patience and lots of soul (kindness) especially a Dr. that loves his work and his patients.
Reviewed on Aug 26, 2019
Dr Ritter is an excellent provider. A good listener. Explains your situation clearly. Professional and caring in the way he relates to you. In short, he's the best!
Reviewed on Aug 20, 2019
I liked Dr Rutter very much.
Reviewed on Aug 20, 2019
the care, concern, and expertise of Dr Ritter is exceptional
Reviewed on Aug 20, 2019
Dr Ritter is an exceptional doctor!
Reviewed on Aug 20, 2019
dr. Ritter is always very helpful in answering our questions and fears.
Reviewed on Aug 12, 2019
Dr Ritter is the kindest and most compassionate person ever. my mom looks forward to her visits with him!
Reviewed on Aug 1, 2019
Provider spent time talking with me and my family. Explained everything during the visit.
Reviewed on Jul 30, 2019
Again, on a scale of 1 to 10, Dr. Ritter was a 10+ .... Very professional, organized, and informative. I look forward to working with him with my medical / mental issues.